Author: Lisa Brown

Second Annual Shine Lecture Explores 'The Dark Side of Research' and the Influence of Money on Medicine

Carl Elliott, author of White Coat, Black Hat: Adventures on the Dark Side of Medicine, is the featured speaker at the Second Annual Cathy Shine Lecture and will present “The Dark Side of Research: Exploitation in Clinical Trials.”

Elliott’s research offers surprising examples of the influence of market forces on medicine. His studies of clinical trials reveal what physicians may not know — from a university’s refusal to investigate a student’s death to the source of research subjects recruited by commercial companies. A physician and bioethicist at the University of Minnesota Medical School, Elliott is also respected as a courageous social commentator, with articles like “Guinea Pigging” in the New Yorker.

Science as Art

Last fall, Karen Antman, MD, Provost, BU Medical Campus, and Dean, BUSM, requested submissions from the Medical Campus community for images derived from science that would be displayed as art throughout the campus. A variety of intricate and striking images rolled out of the laboratories of the campus scientists. Faculty members, postdocs and students all […]

Identifying an “Achilles’ Heel” in Colon Cancer

Over 1 million cases of colon cancer are diagnosed worldwide each year resulting in approximately 600,000 deaths annually. Disease-causing mutations in the KRAS gene are found in over half of these cases. In the United States, colon cancer patients are routinely genotyped for KRAS gene mutations and those with mutations are excluded from receiving novel […]

American College of Dentists Honors Sheede Khalil DMD ‘12

Sheede Khalil DMD ’12 was presented with the American College of Dentists (ACD) Senior Student Award at a luncheon held on Saturday, January 28, at Yankee Dental Congress 37. Khalil was selected because of her outstanding achievements in academics, leadership, and initiative. Khalil came to GSDM as a technical assistant in the lab of Associate […]

Abstracts Sought for 2012 McCahan Education Day

SAVE THE DATE: Medical Campus Education Day, May 23 BUMC faculty, fellows, residents, students and staff are invited to submit proposals for workshops and abstracts of ongoing or completed education projects. Learn new teaching skills and knowledge of education scholarship by attending workshops, viewing posters and hearing presentations about educational innovation, research and scholarship. John […]

Is Pornography a Public Health Issue? SPH Forum Considers Both Sides

n Catharine MacKinnon’s 1993 treatise Only Words, the feminist scholar writes that “the law of equality and the law of freedom of speech are on a collision course in this country.”

This semester, students at the School of Public Health are examining that collision through an unusual lens—not through the study of law or human rights, but through a lesson in hard-core pornography.

Teaching Doctors How to Close Life’s Last Door

At age 78, Charles Swanigan could jog three miles at a stretch. One year later, with the prostate cancer he had battled for a decade spread throughout his body, he could hardly move. Just getting out of bed, he tells his doctor and two BU School of Medicine students paying him an autumn house call, […]

GSDM Holds Inaugural Research Retreat

The Inaugural Boston University Henry M. Goldman School of Dental Medicine Research Retreat was held on Feb. 2, in the Hiebert Lounge. The Retreat was put on by the Office of the Associate Dean for Research, and Associate Dean for Research Maria Kukuruzinska served as host. The event included updates on research from many departments […]

Attend Feb. 21 CTSI Drug & Device Development Seminar, “Partnering With Industry: How to Do It and What Does Industry Want”

Join Charles Wilson, PhD as he discusses Partnering with industry: How to do it and what does industry want. Dr. Wilson serves as Vice President and Global Head of Strategic Alliances, leading the group responsible for externally oriented research at the Novartis Institutes for BioMedical Research (NIBR), the business unit of Novartis responsible for drug […]